Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended		62 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
Income Statement [Abstract]
Revenue	$ 51,818	$ 341,326	$ 165,972	$ 589,926	$ 755,898
Cost of revenue	12,260	54,444	35,274	91,144	126,418
Gross profit	39,558	286,882	130,698	498,782	629,480
General and administrative expenses	502,820	898,946	1,203,887	2,723,393	12,496,167
Research and development expenses	64,735	282,134	126,940	628,204	5,415,334
Total operating expenses	567,555	1,181,080	1,330,827	3,351,597	17,911,501
Loss from operations	(527,997)	(894,198)	(1,200,129)	(2,852,815)	(17,282,021)
Interest expense and other	(25,337)	(30,645)	(155,138)	(52,882)	(742,907)
Loss before income taxes	(553,334)	(924,843)	(1,355,267)	(2,905,697)	(18,024,928)
Income taxes	0	0	0	0	0
Net loss	(553,334)	(924,843)	(1,355,267)	(2,905,697)	(18,024,928)
Deemed dividends to preferred stockholders	(1,286)	(1,500)	(4,286)	(4,500)	(183,113)
Net loss available to common stockholders	$ (554,620)	$ (926,343)	$ (1,359,553)	$ (2,910,197)	$ (18,208,041)
Net loss available to common shareholders per share:
Basic and diluted	$ 0.00	$ (0.01)	$ (0.01)	$ (0.02)
Weighted average shares outstanding:
Basic and diluted	160,767,919	140,793,632	158,090,480	136,643,591